Webinar on Oncology and Breast Cancer

Soo-Foon Moey has worked as a radiographer under the Ministry of Health, Malaysia for 19 years after obtaining the Diploma of Radiography, UK. She specializes in Mammography and Computed Tomography (CT). She furthered her studies in Australia and graduated with a BSc. (Medical Imaging) and Postgraduate Diploma (Med. Imaging Edu.). She started her teaching career in 1997 and has risen from a tutor to the director of the Allied Health Science College, Kuching, Sarawak. She obtained her MSc. (Medical Imaging) from University Malaya and her Ph.D. in Education (Administration & Management) from Universiti Teknologi Malaysia, Malaysia. She is currently an Assistant Professor with IIUM, Kuantan, Pahang. She has published more than 20 papers mainly in the indexed journals. She is also an active reviewer for IJMP, Journal of Nursing Management, Wiley; BMC Geriatrics, Springer and IMJM, IIUM. She is actively involved in research of which the current article is part of the project "Early Breast Cancer Detection: The Development of a Model in Promoting the Behavior of Women towards Breast Self-Examination and Mammogram" financed by the Fundamental Research Grant, Ministry of Higher Education, Malaysia. She has presented numerous papers in Medical Imaging and leadership styles and job satisfaction at local and international conferences.

She studied Oriental Traditional Medicine of Japan, Korea, Taiwan and China. In 2000 she received her PHD and OMD from the International Academy of Education in Tokyo. She established the Oki-Do Holistic Health Center in 1994 in NY and in 2001 the GAIA Holistic Center (501C3 nonprofit organization) at the wake of 9/11 tragedy, for body mind and spirit, aiming for the noninvasive natural healing methods based on the wisdom of the East. She invented special holistic healing method called ONNETSU THERMOTHERAPY using Heat and 2 vibrations of Sun Far Infra-red (8-10μ) and Terahertz from deep earth planet minerals. The therapy has been widely hailed in hospitals and clinics especially in South Americas. Her invention is patent pending worldwide. Dr. Kazuko Tatsumura has written numerous articles and several books: e.g. “Overcoming Cancer and Other Diseases in a Holistic Way”, “Your Immune Revolution & Healing Your Healing Power” (with Toru Abo, M.D.). Dr. Kazuko has been invited as a speaker at various World Congresses & International Conferences on Alternative & Holistic Health. She teaches and lectures to MDs and practitioners all over the world.

DR Jehad Zweiri, lecturer in Cancer studies at the University of Liverpool Medical School, born and grew up in Jordan and received his Bachelor’s degree from the University of Jordan. He obtained his master degree from London School of Hygiene and Tropical Medicine/University of London, and then obtained his PhD degree in 2000 from Kings College Medical School/University of London, in the field of Immune Gene Therapy of Cancer under the supervision of Professor Farzin Farzaneh. He then started his work as Postdoctoral Associate at the department of Immunology and Medicine at the University of Liverpool in 2002. In 2010 he was appointed as a lecturer in the University of Liverpool Medical School and he is currently fellow of the British Higher Education Academy since 2012.

Barrington Brevitt is a PhD candidate at the University of the West Indies (UWI), Mona Campus, Jamaica doing research in Applied Physics. He is also pursuing a Post Graduate Certificate in University Teaching and Learning. He currently possesses a Diploma in Sports Therapy, BSc in Diagnostic Imaging and an MSc in Medical Physics.

Dr. Tarang Krishna is a distinguished and acclaimed physician who has made immense contribution in the field of cancer treatment. A well-known and a fabled personality in healthcare, Dr. Tarang Krishna has successfully treated thousands of patients over a span of 18 years. Dr. Krishna completed his MD and thereafter went on to do his PhD in oncology from University of London. His aim is to promote and spread the awareness of the benefits of immunotherapy to maximum number of people. He has been appreciated and awarded several times by the Government of India as well as by International Organizations.

Dr. Ashok Srivastava, MD, Ph.D, MBA: is Chief Executive Officer and Chief Medical Officer of ClinFomatrix, USA and Chief Executive Officer of Cure Pharmaceuticals, Inc., USA. He has more than 17 years of experience in drug development. He received his clinical, medical training & worked at renowned medical centers and pharmaceutical institutions worldwide; Walter Reed Army Institute of Research and Medical Center, Daiichi, Sumitomo, Pharmacia, Pfizer, Sopherion Oncology., Eisai Oncology, and Spectrum Pharmaceuticals.He played key role in dramatic expansion of oncology drug – developed cancer drugs- Sutent (Sunitinib), Evoxac (Cevimeline HCl), and liposomal doxorubicin (Myocet) in combination with Herceptin & Paclitaxel for HER2 positive metastatic breast cancer patients and Latuda (Lurasidone) for schizophrenia.

Pallavi Dhillon, PharmD, Ph.D., I am at ClinFomatrix, NJ, USA and New Delhi, India, CEO, Head of Clinical Operations and Drug safety, USA, more than 5 years and managing drug safety program globally, Quality Review of ICSRs, write and review safety narratives, pharmacovigilance Control document, monitoring of the compliance of outsourced pharmacovigilance activities. Lead concepts of quality management and inspection readiness within the study Clinical project monitoring and management to ensure that clinical trial project and process work was conducted to internal and external standards. This included ensuring that all colleagues, both internal as well as preferred CROs and partners, were regulatory inspection ready and staff were compliant with ICH GCP and relevant national and international regulations and guidelines and corporate policies and SOPs. Conducting clinical site feasibility studies as well as clinical site identification starting from Phase-I to Phase-IV. Monitoring the clinical sites as per monitoring plan to ensure that Principal Investigator(s) are conducting the study as per Protocol, ICH-GCP & SOPs. I have experience in neuroscience drug development and safety: schizophrenia, depression, mania, bipolar disorder, pediatric bipolar, pediatric schizophrenia, neuropathic pain, inflammation; osteoarthritis in CNS patients. I also have significant experience in Oncology: Phase 1-3 clinical trials, Solid tumor studies; lung cancers, head and neck, breast, liver, colorectal, prostate, ovarian; hematologic tumors, leukemia, myeloma blood disorders. I also led the Cardiovascular: Lipid studies, Women's health: Osteoporosis; migraine, non-interventional studies, Infectious disease: HIV/AIDs; vaccine; upper respiratory tract infections, pediatric sinusitis, Specialty Care/Other Therapy Areas: Inflammation, rheumatology, urology. I completed my doctor of philosophy, master and Bachelor in pharmacy, MDU Rohtak, India. I worked at leading pharmaceutical companies; Baxter Healthcare India, Pharmacovigilance Specialist, India, Pfizer Pharmacovigilance Officer, New Delhi, India, and was responsible for all AEs, SAEs, medication errors, product complaints. Differentiating between Initial and Follow up reports using ARGUS Working on database Pfoenix and ARGUS for comparison of Adverse Events and completing follow-up reports. QC of cases, AEM report forms for any kind of errors. Undergo client mentorship as designated by the project manager. I also worked as Clinical Research Associate, Sir Ganga Ram Hospital, New Delhi, and managed phase 3 protocols, recruitment, patient screening, patient consent forms and follow up management with Investigator. Maintained source documentation and drug accountability, SAEs reporting, maintaining site master file. HIPPA inclusions for IRB/IEC submission. I was Trainee Clinical Research Associate, Clinsys CRO, Noida, India and Assisted in conduction of BA/BE studies. To prepare readiness of the clinical facility and all study/system related documents for the audit process (QA audit, any regulatory Sponsor audit etc) at all / times. I completed internship at Clinsys Clinical Research Organization, Clinical Research Coordinator, Retention/recruitment Patient in India. I am member of Pharmacy Associations of India and a registered pharmacist in India.

Doctor Ioannis G. Papanikolaou is born in Athens. In 2009 he graduates in Medicine with Excellent votation - Medical Degree (MD). During his University studies he is distinguished with 6 University Scholarships from the ‘‘ADSU Foundation’’. Afterwards, he returns in Athens, being selected from the Faculty for a 2 years Postgraduate Programme, which confers the title of Master of Science in ‘‘Robotic Surgery, Minimally Invasive Surgery and Telesurgery’’, in the University of Athens, Medical School in Greece. Doctor Ioannis G. Papanikolaou is specialized in Obstetrics and Gynaecology. Currently, he works as an Obstetrics & Gyaecology specialist in the Humanitas Fertility Center in Humanitas University and Research Hospital in Milan. His academic and clinical enrollment regards mainly Reproductive Endocrinology, Infertility and Gynaecological Endoscopy. He currently works in Humanitas University and Research Hospital in Milan in the position of European Fellow in Reproductive Medicine.

Dr. Geert C. Mudde received a Ph.D. in immunology from the University of Utrecht in 1985 and started his international professional career at the Swiss Institute for Asthma and Allergy Research in Davos in 1989. In 1992 he joined the pharmaceutical/biotech industry, where he held several senior management positions at the Novartis Research Institute in Vienna, Austria, the Parke Davis Research Institute in Fresnes, France, Ingenium Pharmaceuticals, Martinsried, Germany, and at igeneon AG, Vienna, Austria. Finally, in 2006, while joining Baxter BioScience in Vienna as interim manager, Dr. Mudde co-founded the biotech company f-star Biotechnology, where he served as “Chief Scientific Officer” from 2007 to 2009. In 2009, together with Christof Langer, he started to develop the S-TIR™ technology platform for human specific therapeutic vaccines which led to the foundation of S-TARget therapeutics GmbH in 2010. Since then he serves as CSO and managing director for S-TARget therapeutics as well as for the S-TIR™ technology spin-off companies OncoQR ML GmbH and TYG oncology Ltd., which were both founded in 2013.

Miriam Alguero Josa is President and founder of the Spanish and Latinamerica Integrative Oncology Society. She lost both of her parents to cancer and it was when her mother was diagnosed with a brain tumor that she discovered that there were several things patients could do to improve their quality of life and to increase their chances of getting over cancer. She graduated with a major on Comunication Science at University and, after her mother passed away due to a GB, she changed her life 180 degrees to devote herself probono to improve the life of cancer patients. Six years after founding the Integrative Oncology Society she founded Avivate, an on-line school for cancer patients where they can learn all they can do to improve their quality of life.